Sites
- additudemag.com
- add.org
- bbc.com
- cnn.com
- drugabuse.gov
- drugs.com
- emedicinehealth.com
- healthyplace.com
- huffpost.com
- mayoclinic.org
- medicaldaily.com
- medicalnewstoday.com
- nytimes.com
- psychologytoday.com
- sciencedaily.com
- theguardian.com
- usatoday.com
- washingtonpost.com
- webmd.com
Tags
- 3,4-Ethylidenedioxyamphetamine
- 3,4-Methylenedioxyphentermine
- A
- Acetylcholine
- Acid dissociation constant
- Actavis
- Active ingredient
- Adamantane
- Addiction
- Adenosine receptor
- Adjuvant therapy
- Adrenochrome
- Adverse effect
- Aerobic exercise
- Agonist
- Alcohol
- Alcoholism
- Aleph
- Alertness
- Alpha-2 adrenergic receptor
- Alpha-Pyrrolidinopentiophenone
- American Society of Health-System Pharmacists
- Amfepramone
- Amitriptyline
- Ampakine
- AMPA receptor
- Amphetamine
- Anaerobic exercise
- Analgesic
- Anorectic
- Anorexia
- Antidepressant
- Anxiety
- Ariadne
- Aripiprazole
- Arteriosclerosis
- Arylcyclohexylamine
- Aspartic acid
- Atomoxetine
- Attention
- Attentional control
- Attention deficit hyperactivity disorder
- Attention deficit hyperactivity disorder management
- Baclofen
- Basal ganglia
- Beatrice
- Behavioral addiction
- Benfluorex
- Benzofuranylpropylaminopentane
- Benzoic acid
- Benzphetamine
- Benzydamine
- Bibcode
- Biden
- Binding site
- Bioavailability
- Biological half-life
- Biological target
- Biomolecule
- Bipolar disorder
- Blood proteins
- Blurred vision
- BOH
- Boxed warning
- Bromantane
- Bupropion
- Buspirone
- Caffeine
- Calmodulin
- Cannabinoid
- Carbamazepine
- Carbon dioxide
- Carbonic anhydrase
- Cardiac Arrest
- Cardiac arrhythmia
- Cardiovascular disease
- CAS Registry Number
- Catecholamine
- Cathine
- Cathinone
- Cell membrane
- Central nervous system
- Cerebrospinal fluid
- C-Fos
- Chemical synapse
- Chirality
- Circulatory System
- Citicoline
- Clenbuterol
- Clinical trial
- Clonidine
- Cocaine
- Coma
- Combination drug
- Community reinforcement approach and family training
- Competitive inhibition
- Constipation
- Contingency management
- Contraindication
- Controlled Drugs and Substances Act
- Controlled substance
- Controlled Substances Act
- Convulsion
- Cotinine
- Craving
- Cyclic adenosine monophosphate
- CYP2D6
- Cytisine
- DailyMed
- Debate
- Delirium Tremens
- Dendrite
- Dendritic spine
- Depressant
- Desipramine
- Desvenlafaxine
- Detrusor urinae muscle
- Deviance
- Dexmethylphenidate
- Dextroamphetamine
- Dietary supplement
- Distribution
- DNA
- Dobutamine
- DOI
- Dopamine
- Dopamine receptor
- Dopamine receptor D4
- Dopamine reuptake inhibitor
- Dopaminergic
- Dopamine transporter
- Doping in sport
- Droxidopa
- Drug
- Drug Abuse
- DrugBank
- Drug class
- Drug diversion
- Drug Enforcement Administration
- Drug metabolism
- Drug nomenclature
- Drugs controlled by the German Betäubungsmittelgesetz
- Drugs controlled by the UK Misuse of Drugs Act
- Drug withdrawal
- DSM-IV codes
- Duloxetine
- Dysphoria
- Dysuria
- Effect size
- Elimination
- Enantiomer
- Endocytosis
- Endurance
- Enzyme activator
- Ephedrine
- Epinephrine
- Epithelium
- Erectile dysfunction
- Ergine
- Escherichia coli
- Euphoria
- Executive functions
- Fatigue
- FDA
- Federal Food, Drug, and Cosmetic Act
- Fencamfamin
- Fenethylline
- Fenfluramine
- Fever
- Fixation
- Fluid compartments
- Food and Drug Administration
- Gabapentin
- Ganesha
- Gastrointestinal physiology
- Gene
- Gene expression
- Generic drug
- Genitourinary system
- Glaucoma
- Glutamate
- Glutamate transporter
- G protein
- Grading
- Grandiosity
- Guanfacine
- Hallucination
- HDAC1
- HDL
- Histone
- Human body temperature
- Human brain
- Human microbiota
- Human musculoskeletal system
- Hyperkalemia
- Hypersensitivity
- Hypertension
- Hyperthermia
- Hyperthyroidism
- Hypokalemia
- Hypotension
- Imipramine
- Inhibitory control
- Insomnia
- Insufflation
- Intelligence quotient
- International Programme on Chemical Safety
- International Standard Book Number
- International Standard Serial Number
- Intracerebral hemorrhage
- In vitro
- Ion
- Irritability
- Isomer
- JunD
- Ketamine
- Kidney
- Lateral hypothalamus
- L-DOPA
- Ligand
- Ligand-gated ion channel
- Lisdexamfetamine
- LSD
- Lucid Dream
- Lysine
- Magnesium chloride
- Magnetic resonance imaging
- Major League Baseball
- Mania
- Marathon
- MDMA
- Memantine
- Membrane transport protein
- Memory consolidation
- Mental chronometry
- Mephedrone
- Mergers & Acquisitions
- Mescaline
- Messenger RNA
- Metabolic acidosis
- Methamphetamine
- Methedrone
- Methoxphenidine
- Methylenedioxypyrovalerone
- Methylphenidate
- Mirtazapine
- Misuse of Drugs Act 1971
- MMDA
- Modafinil
- Molar mass
- Monoamine oxidase
- Monoamine oxidase inhibitor
- Monoamine releasing agent
- Myalgia
- Mydriasis
- Myocardial infarction
- Naltrexone
- Nancy Mace
- Narcolepsy
- National Basketball Association
- Nausea
- Navigating
- Network meta-analysis
- Neuron
- Neuroplasticity
- Neurotransmission
- Neurotransmitter
- Next
- NF-κB
- Nicotine
- NMDA receptor
- Nootropic
- Norepinephrine
- Norepinephrine reuptake inhibitor
- Nortriptyline
- Nuclear pore
- Nucleus accumbens
- Obesity
- Ondansetron
- Opioid
- Opioid peptide
- Opioid receptor
- Oral administration
- Orexin
- Paraxanthine
- Pemoline
- Performance-enhancing substance
- PH
- Pharmacodynamics
- Pharmacokinetics
- Pharmacotherapy
- Phencyclidine
- Phenethylamine
- Phentermine
- Phenylalanine
- Phenylephrine
- Phenylpropanolamine
- Physical dependence
- Physical strength
- Pill mill
- PMC
- Polyphagia
- Prefrontal cortex
- Priapism
- Prolintane
- Propofol
- Prospective cohort study
- Protein
- Protein kinase A
- Proton-pump inhibitor
- Pseudoephedrine
- Psychopharmacology
- Psychosis
- PubChem
- PubMed
- Pulmonary artery
- Pulmonary edema
- Racemic mixture
- Randomized controlled trial
- Rate of fire
- Rating of perceived exertion
- Raynaud's phenomenon
- Reboxetine
- Receptor antagonist
- Recreational drug use
- Regulation of therapeutic goods
- Respiratory alkalosis
- Respiratory system
- Response element
- Reward system
- Rhabdomyolysis
- Rhinitis medicamentosa
- Riluzole
- Risk factor
- RNA polymerase
- Robert Califf
- Salbutamol
- Salt
- Sedative
- Seizure
- Selective serotonin reuptake inhibitor
- Selegiline
- Self-administration
- Self-confidence
- Self-Efficacy
- Serine
- Serotonin
- Serotonin syndrome
- Serotonin transporter
- Sertraline
- Sexual intercourse
- Sibutramine
- SIC
- Sirtuin 1
- Standard for the Uniform Scheduling of Medicines and Poisons
- Stereotypy
- Stimulant
- Stimulant psychosis
- Stroke
- Sublingual administration
- Substance dependence
- Substance use disorder
- Substituted amphetamine
- Substituted cathinone
- Substituted phenethylamine
- Substituted tryptamine
- Sulfate
- Sympathomimetic drug
- Systematic review
- TAAR1
- Tachycardia
- Telehealth
- Teratology
- Theobromine
- Therapy
- Thujone
- Thyroid
- Tic disorder
- Tiletamine
- Topiramate
- Tourette syndrome
- Toxicity
- Transcriptional regulation
- Tranylcypromine
- Trimethylamine
- Tryptamine
- Tyramine
- Tyrosine
- Urinary incontinence
- Varenicline
- Vasovagal syncope
- Venlafaxine
- Ventral tegmental area
- Vesicular monoamine transporter 2
- Wakefulness
- Weight loss
- Xenobiotic
- Xerostomia
- Yohimbine
- Zinc